{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:16:56Z","timestamp":1742912216014,"version":"3.40.3"},"publisher-location":"Cham","reference-count":60,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030676957"},{"type":"electronic","value":"9783030676964"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-67696-4_10","type":"book-chapter","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T07:20:04Z","timestamp":1622272804000},"page":"197-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Maintenance of Endoplasmic Reticulum Protein Homeostasis in Cancer: Friend or Foe"],"prefix":"10.1007","author":[{"given":"Mari","family":"McMahon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Samali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Chevet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,30]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fmolb.2019.00011","volume":"6","author":"CJ Adams","year":"2019","unstructured":"Adams CJ, Kopp MC, Larburu N, Nowak PR, Ali MMU (2019) Structure and molecular mechanism of er stress signaling by the unfolded protein response signal activator IRE1. Front Mol Biosci 6:11. https:\/\/doi.org\/10.3389\/fmolb.2019.00011","journal-title":"Front Mol Biosci"},{"issue":"2","key":"10_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/febs.14608","volume":"286","author":"A Almanza","year":"2019","unstructured":"Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, Lu\u00eds A et al (2019) Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications. FEBS J 286(2):241\u2013278. https:\/\/doi.org\/10.1111\/febs.14608","journal-title":"FEBS J"},{"issue":"6","key":"10_CR3","doi-asserted-by":"publisher","first-page":"1993 LP","DOI":"10.1158\/0008-5472.CAN-12-3109","volume":"73","author":"C Atkins","year":"2013","unstructured":"Atkins C, Qi L, Minthorn E, Zhang S-Y, Figueroa DJ, Moss K, Stanley TB et al (2013) Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res 73(6):1993 LP\u20131992002. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3109","journal-title":"Cancer Res"},{"issue":"35","key":"10_CR4","doi-asserted-by":"publisher","first-page":"15553","DOI":"10.1073\/pnas.0914072107","volume":"107","author":"G Auf","year":"2010","unstructured":"Auf G, Jabouille A, Gu\u00e9rit S, Pineau R, Delugin M, Bouchecareilh M, Magnin N et al (2010) Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma. Proc Natl Acad Sci U S A 107(35):15553\u201315558. https:\/\/doi.org\/10.1073\/pnas.0914072107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/1471-2407-13-597","volume":"13","author":"G Auf","year":"2013","unstructured":"Auf G, Jabouille A, Delugin M, Gu\u00e9rit S, Pineau R, North S, Platonova N et al (2013) High epiregulin expression in human u87 glioma cells relies on IRE1\u03b1 and promotes autocrine growth through EGF receptor. BMC Cancer 13(1):597. https:\/\/doi.org\/10.1186\/1471-2407-13-597","journal-title":"BMC Cancer"},{"issue":"16","key":"10_CR6","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1021\/jm300713s","volume":"55","author":"JM Axten","year":"2012","unstructured":"Axten JM, Medina JR, Feng Y, Shu A, Romeril SP, Grant SW, Li WHH et al (2012) Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1h-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem 55(16):7193\u20137207. https:\/\/doi.org\/10.1021\/jm300713s","journal-title":"J Med Chem"},{"issue":"10","key":"10_CR7","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1021\/ml400228e","volume":"4","author":"JM Axten","year":"2013","unstructured":"Axten JM, Romeril SP, Shu A, Ralph J, Medina JR, Feng Y, Li WHH et al (2013) Discovery of GSK2656157: an optimized PERK inhibitor selected for preclinical development. ACS Med Chem Lett 4(10):964\u2013968. https:\/\/doi.org\/10.1021\/ml400228e","journal-title":"ACS Med Chem Lett"},{"issue":"37","key":"10_CR8","doi-asserted-by":"publisher","first-page":"9900 LP","DOI":"10.1073\/pnas.1701757114","volume":"114","author":"N Blazanin","year":"2017","unstructured":"Blazanin N, Son J, Craig-Lucas AB, John CL, Breech KJ, Podolsky MA, Glick AB (2017) ER stress and distinct outputs of the IRE1\u03b1 RNase control proliferation and senescence in response to oncogenic ras. Proc Natl Acad Sci U S A 114(37):9900 LP\u20139909905. https:\/\/doi.org\/10.1073\/pnas.1701757114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10_CR9","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/jcp.25336","volume":"231","author":"Y Bu","year":"2016","unstructured":"Bu Y, Diehl JA (2016) PERK integrates oncogenic signaling and cell survival during cancer development. J Cell Physiol 231(10):2088\u20132096. https:\/\/doi.org\/10.1002\/jcp.25336","journal-title":"J Cell Physiol"},{"issue":"17","key":"10_CR10","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1182\/blood-2016-09-741348","volume":"129","author":"B Bujisic","year":"2017","unstructured":"Bujisic B, De Gassart A, Tallant R, Demaria O, Zaffalon L, Chelbi S, Gilliet M, Bertoni F, Martinon F (2017) Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth. Blood 129(17):2420\u20132428. https:\/\/doi.org\/10.1182\/blood-2016-09-741348","journal-title":"Blood"},{"issue":"4","key":"10_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ccr.2007.02.015","volume":"11","author":"DR Carrasco","year":"2007","unstructured":"Carrasco DR, Sukhdeo K, Protopopova M, Sinha R, Enos M, Carrasco DE, Zheng M et al (2007) The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell 11(4):349\u2013360. https:\/\/doi.org\/10.1016\/j.ccr.2007.02.015","journal-title":"Cancer Cell"},{"issue":"7494","key":"10_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature13119","volume":"508","author":"X Chen","year":"2014","unstructured":"Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, Lim E et al (2014) XBP1 promotes triple negative breast cancer by controlling the HIF1 \u03b1 pathway. Nature 508(7494):103\u2013107. https:\/\/doi.org\/10.1038\/nature13119","journal-title":"Nature"},{"issue":"4","key":"10_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nsmb.2793","volume":"21","author":"JC Christianson","year":"2014","unstructured":"Christianson JC, Ye Y (2014) Cleaning up in the endoplasmic reticulum: ubiquitin in charge. Nat Struct Mol Biol 21(4):325\u2013335. https:\/\/doi.org\/10.1038\/nsmb.2793","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"10_CR14","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/cancers11050614","volume":"11","author":"G D\u2019Orazi","year":"2019","unstructured":"D\u2019Orazi G, Cirone M (2019) Mutant P53 and cellular stress pathways: a criminal alliance that promotes cancer progression. Cancers 11(5):614. https:\/\/doi.org\/10.3390\/cancers11050614","journal-title":"Cancers"},{"issue":"18","key":"10_CR15","first-page":"4278","volume":"125","author":"N Dejeans","year":"2012","unstructured":"Dejeans N, Pluquet O, Lhomond S, Grise F, Bouchecareilh M, Juin A, Meynard-Cadars M et al (2012) Autocrine control of glioma cells adhesion and migration through IRE1\u03b1-mediated cleavage of SPARC MRNA. J Cell Sci 125(18):4278\u20134287. http:\/\/jcs.biologists.org\/content\/125\/18\/4278.abstract","journal-title":"J Cell Sci"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"e11878","DOI":"10.7554\/eLife.11878","volume":"5","author":"CM Gallagher","year":"2016","unstructured":"Gallagher CM, Garri C, Cain EL, Ang KK-H, Wilson CG, Chen S, Hearn BR et al (2016) Ceapins are a new class of unfolded protein response inhibitors, selectively targeting the ATF6\u03b1 branch. Elife 5:e11878. https:\/\/doi.org\/10.7554\/eLife.11878","journal-title":"Elife"},{"issue":"4","key":"10_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.chembiol.2019.01.010","volume":"26","author":"I Gamayun","year":"2019","unstructured":"Gamayun I, O\u2019Keefe S, Pick T, Klein M-C, Nguyen D, McKibbin C, Piacenti M et al (2019) Eeyarestatin compounds selectively enhance sec61-mediated Ca2+ leakage from the endoplasmic reticulum. Cell Chem Biol 26(4):571\u2013583.e6. https:\/\/doi.org\/10.1016\/j.chembiol.2019.01.010","journal-title":"Cell Chem Biol"},{"issue":"1","key":"10_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/cancers11010066","volume":"11","author":"MHZ Guang","year":"2019","unstructured":"Guang MHZ, Kavanagh EL, Dunne LP, Dowling P, Li Z, Lindsay S, Bazou D et al (2019) Targeting proteotoxic stress in cancer: a review of the role that protein quality control pathways play in oncogenesis. Cancers 11(1):66. https:\/\/doi.org\/10.3390\/cancers11010066","journal-title":"Cancers"},{"issue":"3","key":"10_CR19","doi-asserted-by":"publisher","first-page":"e1672","DOI":"10.1038\/cddis.2015.49","volume":"6","author":"M Halliday","year":"2015","unstructured":"Halliday M, Radford H, Sekine Y, Moreno J, Verity N, le Quesne J, Ortori CA et al (2015) Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity. Cell Death Dis 6(3):e1672\u2013e1672. https:\/\/doi.org\/10.1038\/cddis.2015.49","journal-title":"Cell Death Dis"},{"issue":"33","key":"10_CR20","doi-asserted-by":"publisher","first-page":"16420","DOI":"10.1073\/pnas.1906999116","volume":"116","author":"JM Harnoss","year":"2019","unstructured":"Harnoss JM, Le Thomas A, Shemorry A, Marsters SA, Lawrence DA, Min L, Chen Y-CA et al (2019) Disruption of IRE1\u03b1 through its kinase domain attenuates multiple myeloma. Proc Natl Acad Sci U S A 116(33):16420\u201316429. https:\/\/doi.org\/10.1073\/pnas.1906999116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10_CR21","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1172\/JCI62973","volume":"122","author":"LS Hart","year":"2012","unstructured":"Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL, Qiu B et al (2012) ER stress\u2013mediated autophagy promotes myc-dependent transformation and tumor growth. J Clin Invest 122(12):4621\u20134634. https:\/\/doi.org\/10.1172\/JCI62973","journal-title":"J Clin Invest"},{"issue":"7","key":"10_CR22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ncb3184","volume":"17","author":"C Hetz","year":"2015","unstructured":"Hetz C, Chevet E, Oakes SA (2015) Proteostasis control by the unfolded protein response. Nat Cell Biol 17(7):829\u2013838. https:\/\/doi.org\/10.1038\/ncb3184","journal-title":"Nat Cell Biol"},{"issue":"10","key":"10_CR23","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1128\/MCB.01484-13","volume":"34","author":"A Higa","year":"2014","unstructured":"Higa A, Taouji S, Lhomond S, Jensen D, Fernandez-Zapico ME, Simpson JC, Pasquet J-M, Schekman R, Chevet E (2014) Endoplasmic reticulum stress-activated transcription factor ATF6\u03b1 requires the disulfide isomerase PDIA5 to modulate chemoresistance. Mol Cell Biol 34(10):1839\u20131849. https:\/\/doi.org\/10.1128\/MCB.01484-13","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12929-018-0453-1","volume":"25","author":"RF Hillary","year":"2018","unstructured":"Hillary RF, FitzGerald U (2018) A lifetime of stress: ATF6 in development and homeostasis. J Biomed Sci 25(1):48. https:\/\/doi.org\/10.1186\/s12929-018-0453-1","journal-title":"J Biomed Sci"},{"issue":"11","key":"10_CR25","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1038\/s41375-018-0141-x","volume":"32","author":"LN Huiting","year":"2018","unstructured":"Huiting LN, Samaha Y, Zhang GL, Roderick JE, Li B, Anderson NM, Wang YW et al (2018) UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response. Leukemia 32(11):2339\u20132351. https:\/\/doi.org\/10.1038\/s41375-018-0141-x","journal-title":"Leukemia"},{"issue":"23","key":"10_CR26","doi-asserted-by":"publisher","first-page":"11291","DOI":"10.1073\/pnas.1904516116","volume":"116","author":"A Igbaria","year":"2019","unstructured":"Igbaria A, Merksamer PI, Trusina A, Tilahun F, Johnson JR, Brandman O, Krogan NJ, Weissman JS, Papa FR (2019) Chaperone-mediated reflux of secretory proteins to the cytosol during endoplasmic reticulum stress. Proc Natl Acad Sci 116(23):11291\u201311298. https:\/\/doi.org\/10.1073\/pnas.1904516116","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/febs.14589","volume":"286","author":"H Kadowaki","year":"2019","unstructured":"Kadowaki H, Nishitoh H (2019) Endoplasmic reticulum quality control by garbage disposal. FEBS J 286(2):232\u2013240. https:\/\/doi.org\/10.1111\/febs.14589","journal-title":"FEBS J"},{"issue":"21","key":"10_CR28","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.1128\/MCB.22.21.7405-7416.2002","volume":"22","author":"C Koumenis","year":"2002","unstructured":"Koumenis C, Naczki C, Koritzinsky M, Rastani S, Diehl A, Sonenberg N, Koromilas A, Wouters BG (2002) Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor EIF2\u03b1. Mol Cell Biol 22(21):7405\u20137416. https:\/\/doi.org\/10.1128\/MCB.22.21.7405-7416.2002","journal-title":"Mol Cell Biol"},{"key":"10_CR29","doi-asserted-by":"publisher","unstructured":"Lajoie P, Snapp EL (2019) Size-dependent secretory protein reflux into the cytosol in association with acute endoplasmic reticulum stress. BioRxiv. https:\/\/doi.org\/10.1101\/573428","DOI":"10.1101\/573428"},{"issue":"3","key":"10_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccr.2013.08.009","volume":"24","author":"C Leung-Hagesteijn","year":"2013","unstructured":"Leung-Hagesteijn C, Erdmann N, Cheung G, Keats JJ, Stewart AK, Reece DE, Chung KC, Tiedemann RE (2013) Xbp1s-negative tumor b cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma. Cancer Cell 24(3):289\u2013304. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.009","journal-title":"Cancer Cell"},{"issue":"3","key":"10_CR31","doi-asserted-by":"publisher","first-page":"e7929","DOI":"10.15252\/emmm.201707929","volume":"10","author":"S Lhomond","year":"2018","unstructured":"Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R et al (2018) Dual IRE1 RNase functions dictate glioblastoma development. EMBO Mol Med 10(3):e7929. http:\/\/embomolmed.embopress.org\/content\/10\/3\/e7929.abstract","journal-title":"EMBO Mol Med"},{"issue":"48","key":"10_CR32","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1038\/onc.2017.284","volume":"36","author":"X-X Li","year":"2017","unstructured":"Li X-X, Zhang H-S, Xu Y-M, Zhang R-J, Chen Y, Fan L, Qin Y-Q, Liu Y, Li M, Fang J (2017) Knockdown of IRE1\u03b1 inhibits colonic tumorigenesis through decreasing \u03b2-catenin and IRE1\u03b1 targeting suppresses colon cancer cells. Oncogene 36(48):6738\u20136746. https:\/\/doi.org\/10.1038\/onc.2017.284","journal-title":"Oncogene"},{"issue":"1","key":"10_CR33","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1038\/s41467-018-05763-8","volume":"9","author":"SE Logue","year":"2018","unstructured":"Logue SE, McGrath EP, Cleary P, Greene S, Mnich K, Almanza A, Chevet E et al (2018) Inhibition of IRE1 RNase Activity Modulates the Tumor Cell Secretome and Enhances Response to Chemotherapy. Nat Commun 9(1):3267. https:\/\/doi.org\/10.1038\/s41467-018-05763-8","journal-title":"Nat Commun"},{"issue":"1","key":"10_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/boc.201800050","volume":"111","author":"E Madden","year":"2019","unstructured":"Madden E, Logue SE, Healy SJ, Manie S, Samali A (2019) The role of the unfolded protein response in cancer progression: from oncogenesis to chemoresistance. Biol Cell 111(1):1\u201317. https:\/\/doi.org\/10.1111\/boc.201800050","journal-title":"Biol Cell"},{"issue":"5","key":"10_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2014.02.008","volume":"39","author":"M Maurel","year":"2014","unstructured":"Maurel M, Chevet E, Tavernier J, Gerlo S (2014) Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem Sci 39(5):245\u2013254. https:\/\/doi.org\/10.1016\/j.tibs.2014.02.008","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10_CR36","doi-asserted-by":"publisher","first-page":"227 LP","DOI":"10.1042\/EBC20160003","volume":"60","author":"K McCaffrey","year":"2016","unstructured":"McCaffrey K, Braakman I (2016) Protein quality control at the endoplasmic reticulum. Essays Biochem 60(2):227 LP\u2013227235. https:\/\/doi.org\/10.1042\/EBC20160003","journal-title":"Essays Biochem"},{"issue":"24","key":"10_CR37","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1182\/blood-2011-07-366633","volume":"119","author":"N Mimura","year":"2012","unstructured":"Mimura N, Fulciniti M, Gorgun G, Tai Y-T, Cirstea D, Santo L, Yiguo H et al (2012) Blockade of XBP1 splicing by inhibition of IRE1\u03b1 is a promising therapeutic option in multiple myeloma. Blood 119(24):5772\u20135781. https:\/\/doi.org\/10.1182\/blood-2011-07-366633","journal-title":"Blood"},{"issue":"1","key":"10_CR38","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/bcr3373","volume":"15","author":"A Nagelkerke","year":"2013","unstructured":"Nagelkerke A, Bussink J, Mujcic H, Wouters BG, Lehmann S, Sweep FCGJ, Span PN (2013) Hypoxia stimulates migration of breast cancer cells via the PERK\/ATF4\/LAMP3-arm of the unfolded protein response. Breast Cancer Res 15(1):R2. https:\/\/doi.org\/10.1186\/bcr3373","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/10428190500312196","volume":"47","author":"M Nakamura","year":"2006","unstructured":"Nakamura M, Gotoh T, Okuno Y, Tatetsu H, Sonoki T, Uneda S, Mori M, Mitsuya H, Hata H (2006) Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leuk Lymphoma 47(3):531\u2013539. https:\/\/doi.org\/10.1080\/10428190500312196","journal-title":"Leuk Lymphoma"},{"issue":"24","key":"10_CR40","doi-asserted-by":"publisher","first-page":"19990","DOI":"10.18632\/oncotarget.4598","volume":"6","author":"T Namba","year":"2015","unstructured":"Namba T, Chu K, Kodama R, Byun S, Yoon KW, Hiraki M, Mandinova A, Lee SW (2015) Loss of P53 enhances the function of the endoplasmic reticulum through activation of the IRE1\u03b1\/XBP1 pathway. Oncotarget 6(24):19990\u201320001. http:\/\/legacy.oncotarget.com\/index.php?journal=oncotarget&amp","journal-title":"Oncotarget"},{"issue":"8","key":"10_CR41","doi-asserted-by":"publisher","first-page":"a033928","DOI":"10.1101\/cshperspect.a033928","volume":"11","author":"PG Needham","year":"2019","unstructured":"Needham PG, Guerriero CJ, Brodsky JL (2019) Chaperoning endoplasmic reticulum\u2013associated degradation (ERAD) and protein conformational diseases. Cold Spring Harb Perspect Biol 11(8):a033928. https:\/\/doi.org\/10.1101\/cshperspect.a033928","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"439","key":"10_CR42","doi-asserted-by":"publisher","first-page":"eaar2036","DOI":"10.1126\/scitranslmed.aar2036","volume":"10","author":"HG Nguyen","year":"2018","unstructured":"Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC et al (2018) Development of a stress response therapy targeting aggressive prostate cancer. Sci Transl Med 10(439):eaar2036. https:\/\/doi.org\/10.1126\/scitranslmed.aar2036","journal-title":"Sci Transl Med"},{"issue":"12","key":"10_CR43","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.trecan.2020.07.006","volume":"6","author":"D Pelizzari-Raymundo","year":"2020","unstructured":"Pelizzari-Raymundo D, Doultsinos D, Guillory X, Carlesso A, Eriksson LA, Chevet E (2020) Pharmacological targeting of IRE1 in cancer. Trends Cancer 6(12):1018\u20131030. https:\/\/doi.org\/10.1016\/j.trecan.2020.07.006","journal-title":"Trends Cancer"},{"issue":"10","key":"10_CR44","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41419-019-1934-1","volume":"10","author":"NM Pe\u00f1aranda-Fajardo","year":"2019","unstructured":"Pe\u00f1aranda-Fajardo NM, Meijer C, Liang Y, Dijkstra BM, Aguirre-Gamboa R, den Dunnen WFA, Kruyt FAE (2019) ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation. Cell Death Dis 10(10):690. https:\/\/doi.org\/10.1038\/s41419-019-1934-1","journal-title":"Cell Death Dis"},{"issue":"15","key":"10_CR45","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.1158\/0008-5472.CAN-12-3989","volume":"73","author":"O Pluquet","year":"2013","unstructured":"Pluquet O, Dejeans N, Bouchecareilh M, Lhomond S, Pineau R, Higa A, Delugin M et al (2013) Posttranscriptional regulation of PER1 underlies the oncogenic function of IRE\u03b1. Cancer Res 73(15):4732\u20134743. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3989","journal-title":"Cancer Res"},{"issue":"2","key":"10_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40268-019-0269-9","volume":"19","author":"P Robak","year":"2019","unstructured":"Robak P, Robak T (2019) Bortezomib for the treatment of hematologic malignancies: 15 years later. Drugs R&D 19(2):73\u201392. https:\/\/doi.org\/10.1007\/s40268-019-0269-9","journal-title":"Drugs R&D"},{"issue":"6","key":"10_CR47","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/cdd.2017.58","volume":"24","author":"D Rojas-Rivera","year":"2017","unstructured":"Rojas-Rivera D, Delvaeye T, Roelandt R, Nerinckx W, Augustyns K, Vandenabeele P, Bertrand MJM (2017) When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157. Cell Death Differ 24(6):1100\u20131110. https:\/\/doi.org\/10.1038\/cdd.2017.58","journal-title":"Cell Death Differ"},{"issue":"7","key":"10_CR48","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.molmed.2018.05.005","volume":"24","author":"C Rubio-Pati\u00f1o","year":"2018","unstructured":"Rubio-Pati\u00f1o C, Bossowski JP, Chevet E, Ricci J-E (2018) Reshaping the immune tumor microenvironment through IRE1 signaling. Trends Mol Med 24(7):607\u2013614. https:\/\/doi.org\/10.1016\/j.molmed.2018.05.005","journal-title":"Trends Mol Med"},{"issue":"1","key":"10_CR49","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41467-018-08152-3","volume":"10","author":"X Sheng","year":"2019","unstructured":"Sheng X, Nenseth HZ, Su Q, Kuzu OF, Frahnow T, Simon L, Greene S et al (2019) IRE1\u03b1-XBP1s pathway promotes prostate cancer by activating c-MYC signaling. Nat Commun 10(1):323. https:\/\/doi.org\/10.1038\/s41467-018-08152-3","journal-title":"Nat Commun"},{"issue":"34","key":"10_CR50","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1038\/s41388-019-0878-3","volume":"38","author":"D Sicari","year":"2019","unstructured":"Sicari D, Fantuz M, Bellazzo A, Valentino E, Apollonio M, Pontisso I, Di Cristino F et al (2019) Mutant P53 improves cancer cells\u2019 resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6. Oncogene 38(34):6184\u20136195. https:\/\/doi.org\/10.1038\/s41388-019-0878-3","journal-title":"Oncogene"},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ceb.2018.06.004","volume":"53","author":"A Spang","year":"2018","unstructured":"Spang A (2018) The endoplasmic reticulum-the caring mother of the cell. Curr Opin Cell Biol 53:92\u201396. https:\/\/doi.org\/10.1016\/j.ceb.2018.06.004","journal-title":"Curr Opin Cell Biol"},{"issue":"10","key":"10_CR52","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1083\/jcb.201906047","volume":"218","author":"Z Sun","year":"2019","unstructured":"Sun Z, Brodsky JL (2019) Protein quality control in the secretory pathway. J Cell Biol 218(10):3171\u20133187. https:\/\/doi.org\/10.1083\/jcb.201906047","journal-title":"J Cell Biol"},{"issue":"6","key":"10_CR53","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1172\/JCI73448","volume":"124","author":"C-HA Tang","year":"2014","unstructured":"Tang C-HA, Ranatunga S, Kriss CL, Cubitt CL, Tao J, Pinilla-Ibarz JA, Del Valle JR, Hu C-CA (2014) Inhibition of ER stress\u2013associated IRE-1\/XBP-1 pathway reduces leukemic cell survival. J Clin Invest 124(6):2585\u20132598. https:\/\/doi.org\/10.1172\/JCI73448","journal-title":"J Clin Invest"},{"key":"10_CR54","doi-asserted-by":"publisher","first-page":"e46595","DOI":"10.7554\/eLife.46595","volume":"8","author":"SE Torres","year":"2019","unstructured":"Torres SE, Gallagher CM, Plate L, Gupta M, Liem CR, Guo X, Tian R et al (2019) Ceapins block the unfolded protein response sensor ATF6\u03b1 by inducing a neomorphic inter-organelle tether. elife 8:e46595. https:\/\/doi.org\/10.7554\/eLife.46595","journal-title":"elife"},{"issue":"5","key":"10_CR55","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2016.03.007","volume":"2","author":"H Urra","year":"2017","unstructured":"Urra H, Dufey E, Avril T, Chevet E, Hetz C (2017) Endoplasmic reticulum stress and the hallmarks of cancer. Trends Cancer 2(5):252\u2013262. https:\/\/doi.org\/10.1016\/j.trecan.2016.03.007","journal-title":"Trends Cancer"},{"key":"10_CR56","doi-asserted-by":"publisher","unstructured":"Urra H, Daniel R Henriquez, Jos\u00e9 C\u00e1novas, David Villarroel-Campos, Amado Carreras-Sureda, Eduardo Pulgar, Emiliano Molina, et al. (2018) IRE1\u03b1 governs cytoskeleton remodelling and cell migration through a direct interaction with filamin A. Nat Cell Biol 20(8):942\u2013953. https:\/\/doi.org\/10.1038\/s41556-018-0141-0","DOI":"10.1038\/s41556-018-0141-0"},{"issue":"1","key":"10_CR57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12072-014-9582-0","volume":"9","author":"Y-P Vandewynckel","year":"2015","unstructured":"Vandewynckel Y-P, Laukens D, Bogaerts E, Paridaens A, Van den Bussche A, Verhelst X, Van Steenkiste C et al (2015) Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy. Hepatol Int 9(1):93\u2013104. https:\/\/doi.org\/10.1007\/s12072-014-9582-0","journal-title":"Hepatol Int"},{"issue":"5","key":"10_CR58","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.molcel.2017.01.020","volume":"65","author":"V Vliet","year":"2017","unstructured":"Vliet V, Alexander FG, Gerlo S, Segura I, Van Eygen S, Molenberghs G, Rocha S et al (2017) The ER stress sensor PERK coordinates ER-plasma membrane contact site formation through interaction with Filamin-A and F-Actin remodeling. Mol Cell 65(5):885\u2013899.e6. https:\/\/doi.org\/10.1016\/j.molcel.2017.01.020","journal-title":"Mol Cell"},{"issue":"4","key":"10_CR59","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1172\/JCI95864","volume":"128","author":"H Xie","year":"2018","unstructured":"Xie H, Tang C-HA, Song JH, Mancuso A, Del Valle JR, Cao J, Xiang Y et al (2018) IRE1\u03b1 RNase\u2013dependent lipid homeostasis promotes survival in Myc-transformed cancers. J Clin Invest 128(4):1300\u20131316. https:\/\/doi.org\/10.1172\/JCI95864","journal-title":"J Clin Invest"},{"issue":"4","key":"10_CR60","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1172\/JCI95873","volume":"128","author":"N Zhao","year":"2018","unstructured":"Zhao N, Cao J, Xu L, Tang Q, Dobrolecki LE, Lv X, Talukdar M et al (2018) Pharmacological targeting of MYC-regulated IRE1\/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest 128(4):1283\u20131299. https:\/\/doi.org\/10.1172\/JCI95873","journal-title":"J Clin Invest"}],"container-title":["Progress in Molecular and Subcellular Biology","Cellular Biology of the Endoplasmic Reticulum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-67696-4_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T07:21:38Z","timestamp":1622272898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-67696-4_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030676957","9783030676964"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-67696-4_10","relation":{},"ISSN":["0079-6484","2197-8484"],"issn-type":[{"type":"print","value":"0079-6484"},{"type":"electronic","value":"2197-8484"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"30 May 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}